Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin

ABSTRACT: Background: The efficacy of flibanserin in treating hypoactive sexual desire disorder (HSDD) is based upon statistically significant improvements in sexual desire, satisfying sexual events, and distress. However, clinically meaningful benefit has not been well characterized. Aim: Evaluate...

Full description

Bibliographic Details

Published in:	Sexual Medicine
Main Authors:	James A. Simon, MD, Anita H. Clayton, MD, Noel N. Kim, PhD, Sejal Patel, PhD
Format:	Article
Language:	English
Published:	Oxford University Press 2022-02-01
Subjects:	hypoactive sexual desire disorder flibanserin clinically meaningful benefit anchor-based analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2050116121001562